Please login to the form below

Not currently logged in
Email:
Password:

Ehlers-Danlos syndrome

This page shows the latest Ehlers-Danlos syndrome news and features for those working in and with pharma, biotech and healthcare.

Acer Therapeutics hit by FDA filing rejection

Acer Therapeutics hit by FDA filing rejection

Shares plunge as regulator calls for new trial. The FDA has refused to accept the filing of a rare disease treatment for vascular Ehlers-Danlos syndrome (vEDS) from Acer Therapeutics. ... Edsivo is being developed for vascular Ehlers-Danlos syndrome (vEDS

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...